0001127602-18-007606.txt : 20180221
0001127602-18-007606.hdr.sgml : 20180221
20180221181023
ACCESSION NUMBER: 0001127602-18-007606
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180216
FILED AS OF DATE: 20180221
DATE AS OF CHANGE: 20180221
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stejbach Mark
CENTRAL INDEX KEY: 0001487937
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35299
FILM NUMBER: 18629889
MAIL ADDRESS:
STREET 1: C/O TENGION, INC.
STREET 2: 2900 POTSHOP LANE, SUITE 100
CITY: EAST NORRITON
STATE: PA
ZIP: 19403
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alkermes plc.
CENTRAL INDEX KEY: 0001520262
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981007018
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CONNAUGHT HOUSE
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN 4
STATE: L2
ZIP: 00000
BUSINESS PHONE: 00-353-1-772-8000
MAIL ADDRESS:
STREET 1: CONNAUGHT HOUSE
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN 4
STATE: L2
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC
DATE OF NAME CHANGE: 20110804
FORMER COMPANY:
FORMER CONFORMED NAME: Antler Science Two Ltd
DATE OF NAME CHANGE: 20110509
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2018-02-16
0001520262
Alkermes plc.
ALKS
0001487937
Stejbach Mark
852 WINTER ST.
WALTHAM
MA
02451
1
SVP/Chief Comm Off, Alks Inc
Ordinary Shares
2018-02-16
4
M
0
10880
17.30
A
54893
D
Ordinary Shares
2018-02-16
4
S
0
10880
70.5048
D
44013
D
Ordinary Shares
2018-02-17
4
M
0
3000
0
A
47013
D
Ordinary Shares
2018-02-17
4
F
0
884
67.26
D
46129
D
Employee Stock Option (Right to Buy)
17.30
2018-02-16
4
M
0
10880
0
D
2022-03-07
Ordinary Shares
10880
5780
D
Employee Stock Option (Right to Buy)
67.26
2018-02-16
4
A
0
54500
0
A
2019-02-16
2028-02-16
Ordinary Shares
54500
54500
D
Restricted Stock Unit Award
0
2018-02-16
4
A
0
13500
0
A
2019-02-16
Ordinary Shares
13500
13500
D
Restricted Stock Unit Award
0
2018-02-17
4
M
0
3000
0
D
2018-02-17
Ordinary Shares
3000
9000
D
This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/5/17.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/5/17.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.14 to $70.97. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
These options are fully vested in accordance with their terms.
Shares subject to the stock option award vest in four equal annual installments commencing on 2/16/2019.
Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/16/19.
Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/17/18.
/s/ Jennifer Baptiste, attorney-in-fact for Mark Stejbach
2018-02-21